SCHEMBL8091334

SCHEMBL8091334

Clc1cccc2c1CN(NC1=NCCN1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 2/20 1.00
CYP1A2 P05177 1/20 0.61
TSHR P16473 1/20 0.61
ADRA2A P08913 9/20 0.51
ADRA2B P18089 4/20 0.51
ADRA2C P18825 4/20 0.51
LMNA P02545 2/20 0.51
ADRA1D P25100 2/20 0.51
ADRA1A P35348 2/20 0.51
ADRA1B P35368 2/20 0.51
MEN1 O00255 1/20 0.51
SLC22A1 O15245 1/20 0.51
SLC22A3 O75751 1/20 0.51
HTR1A P08908 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
HRH2 P25021 1/20 0.51
CYP2C19 P33261 1/20 0.51
OPRK1 P41145 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6513698 0.99 NISCH (0.97) NISCHCYP1A2TSHRADRA2AADRA2B
SCHEMBL10764582 0.86 NISCH (0.74) NISCHCYP1A2TSHRADRA2AADRA2B
SCHEMBL11001474 0.84 NISCH (0.72) NISCHCYP1A2TSHRADRA2AADRA2B
Isaglidole SCHEMBL114184 0.84 NISCH (0.72) NISCHCYP1A2TSHRADRA2AADRA2B
Isaglidole SCHEMBL30659750 0.84 NISCH (0.72) NISCHCYP1A2TSHRADRA2AADRA2B
SCHEMBL6054462 0.82 NISCH (0.69) NISCHADRA2AADRA2BADRA2CADRA1D
SCHEMBL11097073 0.81 NISCH (0.67) NISCHCYP1A2TSHRADRA2AADRA2B
SCHEMBL11098729 0.79 NISCH (0.65) NISCHADRA2AADRA2BADRA2CLMNA
SCHEMBL8673343 0.76 CYP1A2 (1.00) NISCHCYP1A2TSHRADRA2AADRA2B
SCHEMBL29766842 0.76 CYP1A2 (1.00) NISCHCYP1A2TSHRADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0254777-B1 Use of imidazolinylaminoisoindolines and related compounds for the manufacture of a medicament for the treatment of hyperglycaemia. BEECHAM GROUP PLC (GB) 1992-03-04 EP claimed
EP-0212783-B1 USE OF IMIDAZOLINYLAMINOISOINDOLINES AND RELATED COMPOUNDS IN THE TREATMENT OF HYPERGLYCAEMIA BEECHAM GROUP PLC (GB) 1992-01-08 EP claimed
US-4847280-A HYPOGLYCEMIC AGENTS BEECHAM GROUP PLC (GB) 1989-07-11 US claimed
EP-0254777-A2 Use of imidazolinylaminoisoindolines and related compounds for the manufacture of a medicament for the treatment of hyperglycaemia. BEECHAM GROUP PLC (GB) 1988-02-03 EP claimed
EP-0226199-A2 Isoindole derivatives as medicaments Beiersdorf Aktiengesellschaft (DE) 1987-06-24 EP claimed
EP-0212783-A2 Use of imidazolinylaminoisoindolines and related compounds in the treatment of hyperglycaemia BEECHAM GROUP PLC (GB) 1987-03-04 EP claimed
EP-0072954-B1 ISOINDOLIN-2-YL-AMINO-IMIDAZOLINES AND ISOINDOLIN-2-YL GUANIDINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES Beiersdorf Aktiengesellschaft (DE) 1986-12-30 EP claimed
US-4526897-A Hypertensive agents BEIERSDORF AKTIENGESELLSCHAFT (DE) 1985-07-02 US claimed
EP-0072954-A2 Isoindolin-2-yl-amino-imidazolines and isoindolin-2-yl guanidines, process for their preparation and their use as medicines Beiersdorf Aktiengesellschaft (DE) 1983-03-02 EP claimed
US-4221798-A Hypotensive 2-heterocycloamino-imidazolines BEIERSDORF AKTIENGESELLSCHAFT (DE) 1980-09-09 US claimed
WO-2016105449-A1 COMPOUNDS FOR USE AS PAIN THERAPEUTICS LEDERMAN SETH (US) 2016-06-30 WO disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 WO disclosed
US-6162455-A Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals AMERICAN CYANAMID COMPANY (US) 2000-12-19 US disclosed
US-5141933-A Treatment for hyperglycaemia BEECHAM GROUP P.L.C. (GB) 1992-08-25 US disclosed
EP-0254777-B1 Use of imidazolinylaminoisoindolines and related compounds for the manufacture of a medicament for the treatment of hyperglycaemia. BEECHAM GROUP PLC (GB) 1992-03-04 EP disclosed
EP-0212783-A2 Use of imidazolinylaminoisoindolines and related compounds in the treatment of hyperglycaemia BEECHAM GROUP PLC (GB) 1987-03-04 EP disclosed
EP-0072954-B1 ISOINDOLIN-2-YL-AMINO-IMIDAZOLINES AND ISOINDOLIN-2-YL GUANIDINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES Beiersdorf Aktiengesellschaft (DE) 1986-12-30 EP disclosed
US-4526897-A Hypertensive agents BEIERSDORF AKTIENGESELLSCHAFT (DE) 1985-07-02 US disclosed
EP-0072954-A2 Isoindolin-2-yl-amino-imidazolines and isoindolin-2-yl guanidines, process for their preparation and their use as medicines Beiersdorf Aktiengesellschaft (DE) 1983-03-02 EP disclosed
US-4221798-A Hypotensive 2-heterocycloamino-imidazolines BEIERSDORF AKTIENGESELLSCHAFT (DE) 1980-09-09 US disclosed